檢索結果 - David M. Gershenson

Refine Results
  1. 1
    Update on malignant ovarian germ cell tumors

    Update on malignant ovarian germ cell tumors 由 David M. Gershenson

    出版 1993
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Fertility-Sparing Surgery for Malignancies in Women

    Fertility-Sparing Surgery for Malignancies in Women 由 David M. Gershenson

    出版 2005
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Low-grade serous carcinoma of the ovary or peritoneum

    Low-grade serous carcinoma of the ovary or peritoneum 由 David M. Gershenson

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Sexual dysfunction and treatment for early stage cervical cancer

    Sexual dysfunction and treatment for early stage cervical cancer 由 Leslie R. Schover, Michael Fife, David M. Gershenson

    出版 1989
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum

    Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum 由 David M. Gershenson, Charlotte C. Sun, Kwong‐Kwok Wong

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Unmasking the complexities of mucinous ovarian carcinoma

    Unmasking the complexities of mucinous ovarian carcinoma 由 Michael Frumovitz, Kathleen M. Schmeler, Anaís Malpica, Anil K. Sood, David M. Gershenson

    出版 2010
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Trends of low-grade serous ovarian carcinoma in the United States

    Trends of low-grade serous ovarian carcinoma in the United States 由 Koji Matsuo, Hiroko Machida, Brendan H. Grubbs, Anil K. Sood, David M. Gershenson

    出版 2017
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  8. 8
    Serous borderline tumors of the ovary with noninvasive peritoneal implants

    Serous borderline tumors of the ovary with noninvasive peritoneal implants 由 David M. Gershenson, Elvio G. Silva, Guillermo Tortolero‐Luna, Charles Levenback, Mitchell Morris, Carmen Tornos

    出版 1998
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    The Activity of Taxanes in the Treatment of Sex Cord-Stromal Ovarian Tumors

    The Activity of Taxanes in the Treatment of Sex Cord-Stromal Ovarian Tumors 由 Jubilee Brown, Hyun S. Shvartsman, Michael T. Deavers, Thomas W. Burke, Mark F. Munsell, David M. Gershenson

    出版 2004
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    MEK inhibitor resistance mechanisms and recent developments in combination trials

    MEK inhibitor resistance mechanisms and recent developments in combination trials 由 Eucharist Kun, Yvonne T.M. Tsang, Chun Wai Ng, David M. Gershenson, Kwong‐Kwok Wong

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer

    The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer 由 Erin K. Crane, Charlotte C. Sun, Pedro T. Ramírez, Kathleen M. Schmeler, Anaís Malpica, David M. Gershenson

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)

    Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001) 由 Panagiotis A. Konstantinopoulos, William E. Brady, John Farley, Amy E. Armstrong, Denise Uyar, David M. Gershenson

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Ovarian serous borderline tumors with invasive peritoneal implants

    Ovarian serous borderline tumors with invasive peritoneal implants 由 David M. Gershenson, Elvio G. Silva, Lawrence B. Levy, Thomas W. Burke, Judith K. Wolf, Carmen Tornos

    出版 1998
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    The current status of surgical staging of ovarian serous borderline tumors

    The current status of surgical staging of ovarian serous borderline tumors 由 Paul Lin, David M. Gershenson, Michael W. Bevers, Kristin R. Lucas, Thomas W. Burke, Elvio G. Silva

    出版 1999
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience

    Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience 由 Heather J. Dalton, Nicole D. Fleming, Charlotte C. Sun, Priya Bhosale, Kathleen M. Schmeler, David M. Gershenson

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum

    Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum 由 David M. Gershenson, Diane C. Bodurka, Robert L. Coleman, Karen H. Lu, Anaís Malpica, Charlotte C. Sun

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Subcellular Localization of p27kip1 Expression Predicts Poor Prognosis in Human Ovarian Cancer

    Subcellular Localization of p27kip1 Expression Predicts Poor Prognosis in Human Ovarian Cancer 由 Daniel Rosen, Gong Yang, Kathy Q. Cai, Robert C. Bast, David M. Gershenson, Elvio G. Silva, Jinsong Liu

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Prognosis of surgically determined complete responders in advanced ovarian cancer

    Prognosis of surgically determined complete responders in advanced ovarian cancer 由 David M. Gershenson, Larry J. Copeland, Taylor Wharton, E. Neely Atkinson, Nour Sneige, Creighton L. Edwards, Felix N. Rutledge

    出版 1985
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Survival in Women With Grade 1 Serous Ovarian Carcinoma

    Survival in Women With Grade 1 Serous Ovarian Carcinoma 由 Amanda N. Fader, James Java, Stefanie Ueda, Robert E. Bristow, Deborah K. Armstrong, Michael A. Bookman, David M. Gershenson

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells

    ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells 由 Tsz-Lun Yeung, Cecilia S. Leung, Kwong‐Kwok Wong, Arthur Gutierrez‐Hartmann, Joseph Kwong, David M. Gershenson, Samuel C. Mok

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: